ArticleCureus2025
Negative Pressure Wound Therapy: Significant Improvement in Definitive Fascial Closure With Reduced Theatre Episodes and Complications in Patients With Encapsulating Peritoneal Sclerosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Encapsulating peritoneal sclerosis (EPS) is a rare condition characterised by recurrent episodes of intestinal obstruction and perforation, usually due to prolonged peritoneal dialysis exposure, resulting in abdominal catastrophes often requiring open abdomen management (OAM). Dynamic negative pressure wound therapies (NPWTs) can facilitate definitive closure in the open abdomen, but consensus recommendations lack high-quality, cohort-specific data. We performed a retrospective analysis on the use of NPWTin this patient cohort to assess its effectiveness when compared to management with static management of the open abdomen. Primary endpoints assessed were: (i) definitive closure; (ii) time to definitive closure; and (iii) method of closure. Secondary endpoints included assessment of complications. Multiple linear and logistic regression analysis assessed variables predictive of primary endpoints. 99 patients were included. 43 (43%) patients were managed with NPWT and 56 (57%) patients with static mechanisms (betadine-soaked gauze.) Patients who were managed with NPWTwere more likely to achieve fascial closure (n=27 vs n=7, p<0.0001), required less total theatre episodes (n=2.27 vs 4.78, p<0.0001), and reported less failure to close episodes (p=0.002). The use of NPWTwas associated with fewer returns to theatre following closure within 30 days (n=4 vs n=19, p=0.004). Failure to close was associated with all-cause mortality (p<0.026). This study demonstrates that NPWT is associated with increased likelihood of fascial closure with a reduced complication profile in patients with EPS, representing a chronically malnourished, high-risk surgical cohort. NPWTshould be within the armamentarium of the general surgeon faced with a complex open abdomen and can be safely used in high-risk surgical patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.